Sign in to continue:

Tuesday, February 24th, 2026

Innovex International Reports Strong Q4 and Full-Year 2025 Results: Revenue Growth, Cash Flow, and Subsea Expansion





Innovex International Reports Strong Q4 and Full-Year 2025 Results

Innovex International Reports Strong Q4 and Full-Year 2025 Results

Key Highlights and Investor-Relevant Details

  • Q4 Revenue of \$274 Million: Up 14% quarter-over-quarter, exceeding guidance due to higher subsea product deliveries, revenue synergies from acquisitions, and new product launches.
  • Net Income of \$14 Million: Achieved a 5% net income margin for Q4.
  • Adjusted EBITDA: \$52 million in Q4 with a 19% margin. For the full year, Adjusted EBITDA reached \$188 million (19% margin).
  • Free Cash Flow: \$43 million in Q4, \$156 million for full year 2025. 83% of Adjusted EBITDA converted to Free Cash Flow.
  • Strong Balance Sheet: \$203 million in cash and cash equivalents and no bank debt at year-end, providing significant financial flexibility.
  • Return on Capital Employed (ROCE): 10% for the full year 2025.
  • Operational Milestones:
    • First subsea wellhead products delivered under the global Innovex-OneSubsea alliance.
    • Tenth successful XPak installation in Brazil’s pre-salt fields.
    • Significant progress in exiting the legacy Eldridge facility, with full completion expected by end of Q2 2026.
    • XPak expandable liner adapted and deployed for Permian Basin onshore operations, enabling drilling of technically complex wells.
  • International Expansion:
    • Inaugurated manufacturing facility in Saudi Arabia, strengthening partnership with the Kingdom.
    • Completed major subsea wellhead and tubular deliveries for a major offshore project in Mexico.
    • Secured new significant subsea contracts in Asia and the Mediterranean, including a landmark contract in Brazil with an IOC (first in over a decade).
  • Capital Allocation Strategy: Focused on M&A opportunities aligned with ‘small ticket, big impact’ strategy. All investments are evaluated against share repurchase authorization to maximize shareholder returns.
  • Q1 2026 Guidance:
    • Revenue expected between \$225 – \$235 million.
    • Adjusted EBITDA between \$38 – \$42 million.
    • Sequential revenue decrease due to lower subsea deliveries, reflecting seasonality and accelerated deliveries in Q4.
  • Conference Call: Management will host a webcast on February 24, 2026 at 8:00 a.m. Central Time to discuss results and outlook. Replay will be available.

Detailed Financial Summary

Metric Q4 2025 Q3 2025 Q4 2024 FY 2025 FY 2024
Revenue (\$M) 273.6 240.0 250.7 978.3 660.8
Net Income (\$M) 14.0 39.2 31.8 83.3 140.3
Adjusted EBITDA (\$M) 52.1 43.6 49.1 188.3 138.5
Adjusted EBITDA Margin (%) 19 18 20 19 21
Free Cash Flow (\$M) 43.3 36.5 28.7 155.8 79.8
ROCE (%) 10 12
Cash & Equivalents (\$M) 203.4 73.3
Debt (\$M) 25.6 35.4

Important Price-Sensitive and Shareholder Information

  • Revenue Outperformance and Guidance Beat: Q4 revenue exceeded guidance, largely due to accelerated subsea deliveries and acquisition synergies. This may positively influence share price given the surprise upside.
  • Strong Cash Position and No Bank Debt: The company’s financial flexibility could enable further investments, share repurchases, or dividends, potentially supporting share price.
  • Capital-Light Model and Free Cash Flow Conversion: Innovex converted 83% of Adjusted EBITDA into Free Cash Flow, indicating high cash efficiency and robust capital management.
  • Operational Progress in Subsea and International Markets: Successful contract wins, facility expansions, and new product deployments signal expanding addressable markets and potential future revenue streams.
  • Margin Pressures and Strategic Facility Exit: Corporate margins were weighed down by low-margin subsea projects. The expected exit from the Eldridge facility in Q2 2026 is a key strategic move to improve margins by year-end, potentially impacting future profitability and share price.
  • Share Repurchase Authorization: All investment opportunities are evaluated against share repurchase authorization, highlighting commitment to maximizing returns for shareholders.
  • Q1 2026 Guidance: Anticipated sequential revenue decline due to seasonality and accelerated deliveries may require investor attention, but margin improvement plans and operational momentum are positive offsets.
  • Ongoing M&A Focus: Continued focus on inorganic growth with disciplined capital allocation could drive further expansion and shareholder value.
  • Risks and Forward-Looking Statements: The company highlights risks related to M&A integration, margin pressures, and external factors such as geopolitical risks and macroeconomic conditions, all of which investors should monitor.

Strategic and Operational Updates

  • Innovex is broadening its product suite and international footprint, with strong execution in Saudi Arabia, Mexico, Asia, and Brazil.
  • The Innovex-OneSubsea alliance is expanding the addressable market for subsea products.
  • Strong project execution and global supply chain coordination have resulted in major contract wins and successful product deployments.
  • The company expects margin improvement after the Eldridge facility exit and through optimized bidding practices and manufacturing footprint reduction.

Upcoming Events

  • Conference call and webcast scheduled for February 24, 2026 at 8:00 a.m. Central Time. Replay will be available for those unable to attend live.
  • Investors may contact Eric Wells, Chief of Staff, at [email protected] or (346) 398-0000 for further information.

Conclusion

Innovex International’s Q4 and FY2025 results demonstrate robust financial performance,
strong cash generation, successful operational execution in subsea and international markets,
and a clear focus on capital efficiency and shareholder returns. The company’s guidance beat,
cash position, and strategic facility exit, alongside new contract wins and international expansion,
are all potentially price-sensitive and could impact share values. Investors should monitor
ongoing margin improvement efforts, M&A activity, and management’s commitment to maximizing
returns via share repurchases.


Disclaimer: This article is based on public financial disclosures from Innovex International, Inc. and is intended for informational purposes only. It does not constitute investment advice or a recommendation to buy or sell securities. Investors should conduct their own due diligence and consult with professional advisors before making any investment decisions. The information may contain forward-looking statements subject to risks and uncertainties, and actual results may differ materially from stated expectations.




View Innovex International, Inc. Historical chart here



HCW Biologics Announces $1.5 Million At-The-Market Offering to Advance Immunotherapy Clinical Trials

HCW Biologics Announces \$1.5 Million At-The-Market Follow-On Offering HCW Biologics Announces Pricing of \$1.5 Million Follow-On Offering and Warrant Exercise Price Reduction Key Highlights Offering Details: HCW Biologics Inc. (NASDAQ: HCWB), a clinical-stage biopharmaceutical...

Citigroup Inc. 2025 Annual 10-K Report: Financials, Segments, and Disclosures

Key Highlights Company Profile: Citigroup Inc. is a leading national commercial bank headquartered at 388 Greenwich Street, New York, NY 10013, with a fiscal year ending December 31. The company’s Central Index Key is...

PG&E Corporation $1 Billion 6.85% Fixed-to-Fixed Reset Rate Junior Subordinated Notes Offering: Underwriting Agreement, Terms, and Supplemental Indenture Details

PG&E Corporation Issues \$1 Billion 6.850% Fixed-to-Fixed Reset Rate Junior Subordinated Notes Due 2056 PG&E Corporation Announces \$1 Billion Junior Subordinated Notes Offering Key Highlights for Investors Issuer: PG&E Corporation Security: \$1,000,000,000 aggregate principal...

   Ad